Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Redbaron2211on Oct 29, 2020 4:20pm

87 Views

Post# 31807562

RE:Today’s Presentation

Impressive Philip and the Sernova team have been busy... "Complete enrolment in current FDA trial in 2020 or early 2021" and advancing both thyroid and hemophilia into the clinic. At some point the value here will be unlocked and we will be re-rated closer to our peers. Something tells me at this rate it won't be long.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?